Abstract

Backgroundpara-Tyramine (p-TA) is a biogenic amine which is involved in multiple neuronal signal transductions. Since the concentration of p-TA in dog cerebrospinal fluid (CSF) has been reported to be greater than that in plasma, it is proposed that clearance of cerebral p-TA is important for normal function. The purpose of this study was to examine the role of the blood–brain barrier and blood-cerebrospinal fluid barrier (BCSFB) in p-TA clearance from the brain.MethodsIn vivo [3H]p-TA elimination from rat cerebral cortex and from CSF was examined after intracerebral and intracerebroventricular administration, respectively. To evaluate BCSFB-mediated p-TA transport, [3H]p-TA uptake by isolated rat choroid plexus and conditionally immortalized rat choroid plexus epithelial cells, TR-CSFB3 cells, was performed.ResultsThe half-life of [3H]p-TA elimination from rat CSF was found to be 2.9 min, which is 62-fold faster than that from rat cerebral cortex. In addition, this [3H]p-TA elimination from the CSF was significantly inhibited by co-injection of excess unlabeled p-TA. Thus, carrier-mediated p-TA transport process(es) are assumed to take part in p-TA elimination from the CSF. Since it is known that transporters at the BCSFB participate in compound elimination from the CSF, [3H]p-TA transport in ex vivo and in vitro models of rat BCSFB was examined. The [3H]p-TA uptake by isolated rat choroid plexus and TR-CSFB3 cells was time-dependent and was inhibited by unlabeled p-TA, indicating carrier-mediated p-TA transport at the BCSFB. The p-TA uptake by isolated choroid plexus and TR-CSFB3 cells was not reduced in the absence of extracellular Na+ and Cl−, and in the presence of substrates of typical organic cation transporters. However, this p-TA uptake was significantly inhibited by cationic drugs such as propranolol, imipramine, amantadine, verapamil, and pyrilamine. Moreover, p-TA uptake by TR-CSFB3 cells took place in an oppositely-directed H+ gradient manner. Therefore, this suggested that p-TA transport at the BCSFB involves cationic drug-sensitive transport systems which are distinct from typical plasma membrane organic cation transporters.ConclusionOur study indicates that p-TA elimination from the CSF is greater than that from the cerebral cortex. Moreover, it is suggested that cationic drug-sensitive transport systems in the BCSFB participate in this p-TA elimination from the CSF.

Highlights

  • Background paraTyramine (p-TA) is one of the trace amines derived from tyrosine and present in fermented foods such as Akanuma et al Fluids Barriers CNS (2018) 15:1 dopamine D2 receptor, respectively, are reduced [6,7,8,9,10]

  • The half-life (t1/2) of the percentage of cerebral ­[3H]p-TA remaining after microinjection into the cerebral cortex was calculated to be 178 ± 68 min

  • We have shown that ­[3H]p-TA was time-dependently taken up into ex vivo isolated rat choroid plexus (Fig. 2) and in vitro choroid plexus epithelial cells, which form the blood-cerebrospinal fluid (CSF) barrier (BCSFB) (Fig. 3)

Read more

Summary

Introduction

Background paraTyramine (p-TA) is one of the trace amines derived from tyrosine and present in fermented foods such as Akanuma et al Fluids Barriers CNS (2018) 15:1 dopamine D2 receptor, respectively, are reduced [6,7,8,9,10]. It is considered that the neural concentration of pTA is maintained by a balance between production and clearance and there are reports that the activity of in vivo blood-to-brain transport of p-TA is low [11, 12]. The cerebrospinal fluid (CSF) is separated from the circulating blood by the blood-CSF barrier (BCSFB) composed of choroid plexus epithelial cells [15]. Recent reports have shown that these barriers play a role in brain-to-blood transport of endogenous anionic and cationic compounds such as homovanillic acid and histamine [16, 17]. There is a possibility that the BBB and/or BCSFB transport p-TA from the brain to the circulating blood and play a role in the p-TA clearance system in the brain

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.